Document is current
Any future updates will be listed below
-
Authors
Menato, Francesca
Pepe, Gerardo
Mercuri, Ester
Zangaro, Francesco
Cangialosi, Giulia
Jodice, Carla
Gulì, Martina
Cruciani, Fulvio
Trombetta, Beniamino
Helmer-Citterich, Manuela
D’Atanasio, Eugenia
Guardiano, Cristina
Longobardi, Giuseppe
Semino, Ornella
Novelletto, Andrea
Specchia, Valeria
-
Funding
Funding for this research was provided by:
European Union – Next Generation EU (National Center for Gene Therapy and Drugs based on RNA Technology, CN3 – Spoke 7 (code: CN00000041))
European Union – Next Generation EU (PRIN 2022 BZYFBE)
European Union – Next Generation EU (PRIN 2022 PC2TSX)
- License Information
-
More Information
Article History
Received: 12 May 2025
Accepted: 4 December 2025
First Online: 8 December 2025
Declarations
:
: The authors declare no competing interests.
: To obey all the prescriptions of the EU General Data Protection Regulation, we planned appropriate safeguards for processing data under the research exemption. The samples have been anonymized. Only dedicated, restricted-access bioinformatic infrastructures were used. Electronic data management was supervised by an institutional technology director.
